Juan Carlos Altamirano-Vallejo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Hyaluronic Acid

Placebo Controlled

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dalia Ng, Juan Carlos Altamirano-Vallejo, Luis Carlos Rosales-Rivera, Oscar Eduardo Sanchez-Aguilar, Andres Inzunza, Jorge Eugenio Valdez-Garcia, Alejandro Gonzalez-de-la-Rosa, Andres Bustamante-Arias, Juan Armendáriz-Borunda, Arturo Santos
Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Dalia Ng, Juan Carlos Altamirano-Vallejo, Luis Carlos Rosales-Rivera, Oscar Eduardo Sanchez-Aguilar, Andres Inzunza, Jorge Eugenio Valdez-Garcia, Alejandro Gonzalez-de-la-Rosa, Andres Bustamante-Arias, Juan Armendáriz-Borunda, Arturo Santos
Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Dalia Ng, Juan Carlos Altamirano-Vallejo, Alejandro Gonzalez-de-la-Rosa, Luis Carlos Rosales-Rivera, Jorge Eugenio Valdez-Garcia, Ricardo Acosta-Gonzalez, Juan Carlos Martinez Camarillo, Andres Bustamante-Arias, Juan Armendáriz-Borunda, Arturo Santos
An Oral Polyphenol Formulation to Modulate the Ocular Surface Inflammatory Process and to Improve the Symptomatology Associated with Dry Eye Disease. Nutrients 14 (15) (2022)